SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : The thread of life
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who started this subject8/9/2002 8:31:41 PM
From: scaram(o)ucheRead Replies (1) of 1336
 
I know that CeNeS freaks hang out here. I was looking through my old portfolios, and noticed that I hadn't accommodated the CNSI acquisition.

siliconinvestor.com

Was it a clean deal, no residual royalties to CNSI holders, independent of the buy out, etc.?

What was the final conversion ratio? I can find a description of how it was to be determined........

Each share of CNSI Common Stock will be converted into CeNeS Ordinary
Shares at a value of US$2.25 per CNSI Share. The value of CeNeS Consideration
Shares to be issued will be calculated by reference to the average closing
mid-market price of Ordinary Shares over the 10 trading days ending on the
second trading day prior to Completion converted to US$ by reference to the
average exchange rate for each of those days. This is subject to a minimum and a
maximum price for each CeNeS Consideration Share of US$0.9586 and US$1.3915
respectively.

....... but not of what one actually got.

Thanks for any help.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News